NDC00641-6045-25 — LORAZEPAM INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00641-6045-25: LORAZEPAM INJECTION.

The LORAZEPAM INJECTION is a the manufacturer industrial component. Key specifications include special_features: REFRIGERATION REQUIRED BETWEEN 2-8 DEGREES C. DEA CONTROLLED SUBSTANCE CLASS IV., primary_container_type: VIAL, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 25, primary_container_content_quantity: 1.000 MILLILITERS.

This part is cataloged in the U.S. Government catalog under NSN 6505-01-411-2723, indicating validated use in U.S. government and defense logistics supply chains.

Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels. Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00641-6045-25

NSN: 6505-01-411-2723
FSC: 6505 — Drugs and Biologicals
CAGE: 32655 — HIKMA PHARMACEUTICALS USA INC. (USA)

SPECIFICATIONS

special_features	REFRIGERATION REQUIRED BETWEEN 2-8 DEGREES C. DEA CONTROLLED SUBSTANCE CLASS IV.
primary_container_type	VIAL
protective_storage_feature	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
total_primary_container_quantity	25
primary_container_content_quantity	1.000 MILLILITERS
controlled_substance_classification	SCHEDULE IV
active_medicament_medicinal_strength	4.000 MILLIGRAMS LORAZEPAM PER MILLILITER
part_name_assigned_by_controlling_agency	LORAZEPAM INJECTION 4MG/ML 1ML VIAL 25S PG
NSN	6505-01-411-2723

COMPONENT DIAGRAM

KEY FEATURES

•

CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV

•

PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: VIAL

•

PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER

TECHNICAL CHARACTERISTICS

CONTROLLED SUBSTANCE CLASSIFICATION	SCHEDULE IV
PRIMARY CONTAINER CONTENT QUANTITY	1.000 MILLILITERS
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	VIAL
SPECIAL FEATURES	REFRIGERATION REQUIRED BETWEEN 2-8 DEGREES C. DEA CONTROLLED SUBSTANCE CLASS IV.
PROTECTIVE STORAGE FEATURE	REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
PART NAME ASSIGNED BY CONTROLLING AGENCY	LORAZEPAM INJECTION 4MG/ML 1ML VIAL 25S PG
ACTIVE MEDICAMENT MEDICINAL STRENGTH	4.000 MILLIGRAMS LORAZEPAM PER MILLILITER
TOTAL PRIMARY CONTAINER QUANTITY	25

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

95-0129Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC00641-6045-25?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00641-6045-25?

NDC00641-6045-25 is a LORAZEPAM INJECTION.

What parts can replace NDC00641-6045-25?

There is 1 known substitute for NDC00641-6045-25: 95-0129. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00641-6045-25?

NDC00641-6045-25 is cataloged in the U.S. Government catalog under NSN 6505-01-411-2723. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00641-6045-25 — LORAZEPAM INJECTION

Request a Quote — NDC00641-6045-25